Emerald Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.6M | Sell |
|
|||||
|
2025
Q2 | $16.8M | Sell |
|
|||||
|
2025
Q1 | $18.7M | Sell |
|
|||||
|
2024
Q4 | $21.8M | Sell |
|
|||||
|
2024
Q3 | $31.7M | Buy |
|
|||||
|
2024
Q2 | $20M | Sell |
|
|||||
|
2024
Q1 | $22.8M | Buy |
|
|||||
|
2023
Q4 | $23.1M | Sell |
|
|||||
|
2023
Q3 | $17.5M | Sell |
|
|||||
|
2023
Q2 | $25.5M | Buy |
|
|||||
|
2023
Q1 | $19.7M | Buy |
|
|||||
|
2022
Q4 | $16M | Sell |
|
|||||
|
2022
Q3 | $14.4M | Buy |
|
|||||
|
2022
Q2 | $12M | Sell |
|
|||||
|
2022
Q1 | $16.3M | Sell |
|
|||||
|
2021
Q4 | $19.8M | Buy |
|
|||||
|
2021
Q3 | $17.7M | Sell |
|
|||||
|
2021
Q2 | $20M | Sell |
|
|||||
|
2021
Q1 | $26M | Buy |
|
|||||
|
2020
Q4 | $31.4M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $23.7M | Buy |
|
|||||
|
2016
Q3 | $19.2M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $7.13M | Sell |
|
|||||
|
2015
Q1 | $4.21M | Sell |
|
|||||
|
2014
Q4 | $5.14M | Buy |
|
|||||
|
2014
Q3 | $2.42M | Buy |
|
|||||
|
2014
Q2 | $1.74M | Buy |
|
|||||
|
2014
Q1 | $1.3M | Buy |
|